Back to PTCT

ARMISTICE CAPITAL, LLC → PTCT

ARMISTICE CAPITAL, LLC PTCT Position History

PTC Therapeutics, Inc. • Healthcare

Quarters held
10
Latest value
$58.9M
Q3 2026
Peak value
$212.8M
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$201.1M
Q4 2025$212.8M
Q1 2026$141.3M
Q1 2026$26.6M
Q2 2026$87.4M
Q2 2026$24.5M
Q2 2026$29.4M
Q3 2026$84.1M
Q3 2026$44.1M
Q3 2026$58.9M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$58.9M910.0K——
Q3 2026$44.1M680.0K——
Q3 2026$84.1M1.30M——
Q2 2026$29.4M360.0K——
Q2 2026$24.5M300.0K——
Q2 2026$87.4M1.07M——
Q1 2026$26.6M390.0K——
Q1 2026$141.3M2.07M——
Q4 2025$212.8M2.80M——
Q3 2025$201.1M3.28M——

Other funds holding PTCT

Other ARMISTICE CAPITAL, LLC positions

TVTX

TRAVERE THERAPEUTICS ORD

$160.7M
IMVT

IMMUNOVANT INC

$146.1M
TVTX

TRAVERE THERAPEUTICS INC

$145.5M
TVTX

TRAVERE THERAPEUTICS INC

$143.8M
SUPN

SUPERNUS PHARMACEUTICALS INC

$137.4M
SUPN

SUPERNUS PHARMACEUTICALS ORD

$135.5M
SUPN

SUPERNUS PHARMACEUTICALS

$123.1M
NBIX

NEUROCRINE BIOSCIENCES INC

$116.3M